MD Magazine: Specialty: Ophthalmology Copyright (c) 2017 Intellisphere, LLC. All rights reserved. http://www.mdmag.com/specialty/ophthalmology/rss Ophthalmology en-us Wed, 21 Aug 2019 12:54:50 UTC Potential Dry Eye Therapy KPI-121 Receives FDA CRL http://www.mdmag.com/medical-news/dry-eye-therapy-kpi-121-fda-crl Thu, 15 Aug 2019 14:11:00 UTC FDA Approves Aflibercept Injection Treatment for Retinal Conditions http://www.mdmag.com/medical-news/fda-approves-aflibercept-injection-treatment-retinal-conditions Tue, 13 Aug 2019 14:30:00 UTC Ergonomics May Be the Key to Longevity for Ophthalmologists http://www.mdmag.com/medical-news/ergonomics-longevity-ophthalmologists Tue, 13 Aug 2019 11:00:00 UTC Accuracy of Smartphone-Based AI System for Diabetic Retinopathy http://www.mdmag.com/medical-news/smart-phone-ai-system-for-diabetic-retinopathy Thu, 08 Aug 2019 15:00:00 UTC Short-Term Effects of Ranibizumab Biosimilar Compared to Ranibizumab for DME http://www.mdmag.com/medical-news/ranibizumab-biosimilar-compared-to-ranibizumab-for-dme Thu, 01 Aug 2019 19:56:00 UTC Lawrence Hoffheimer: Legal Hurdles for Retina Specialists http://www.mdmag.com/conference-coverage/asrs-2019/lawrence-hoffheimer-legal-hurdles-for-retina-specialists Thu, 01 Aug 2019 13:00:00 UTC Chirag Jhaveri, MD: 96-Week Visual and Anatomical Outcomes of Brolucizumab http://www.mdmag.com/conference-coverage/asrs-2019/96-week-visual-and-anatomical-outcomes-of-brolucizumab Thu, 01 Aug 2019 11:00:00 UTC Same-Day Treatments Preferred in Patients Receiving Anti-VEGF Therapy http://www.mdmag.com/conference-coverage/asrs-2019/same-day-treatments-preferred-in-anti-vegf-therapy Wed, 31 Jul 2019 17:17:00 UTC Manjot Gill, MD: Baseline Characteristics, Visual Outcomes with Anti-VEGFs http://www.mdmag.com/conference-coverage/asrs-2019/manjot-gill-md-baseline-characteristics-visual-outcomes-with-antivegfs Wed, 31 Jul 2019 13:57:00 UTC Using AI to Identify Diabetic Retinopathy and Clinically Significant DME http://www.mdmag.com/conference-coverage/asrs-2019/using-ai-to-identify-diabetic-retinopathy-and-clinically-significant-dme Wed, 31 Jul 2019 13:00:00 UTC FAi Insert for Treatment of Non-Infectious Posterior Segment Uveitis http://www.mdmag.com/conference-coverage/asrs-2019/fai-insert-for-treatment-of-uveitis Tue, 30 Jul 2019 20:08:00 UTC Vrinda Hershberger, MD, PhD: Faricimab for Diabetic Macular Edema http://www.mdmag.com/conference-coverage/asrs-2019/vrinda-hershberger-md-phd-faricimab-for-diabetic-macular-edema Tue, 30 Jul 2019 18:00:00 UTC Joshua Mali, MD: Evolution of Care for Macular Degeneration http://www.mdmag.com/conference-coverage/asrs-2019/joshua-mali-md-evolution-of-care-for-macular-degeneration Tue, 30 Jul 2019 16:18:00 UTC Biweekly Dosing for Refractory Neovascular Age-Related Macular Degeneration http://www.mdmag.com/conference-coverage/asrs-2019/biweekly-dosing-for-refractory-neovascular-agerelated-macular-degeneration Tue, 30 Jul 2019 15:00:00 UTC Carl Regillo, MD: Positive Impact of Electronic Health Records http://www.mdmag.com/conference-coverage/asrs-2019/carl-regillo-md-positive-impact-of-electronic-health-records Tue, 30 Jul 2019 11:00:00 UTC Baseline Characteristics, Lesion Progression, and Phase 2 FILLY Results http://www.mdmag.com/conference-coverage/asrs-2019/baseline-characteristics-lesion-progression-and-phase-2-filly-results Mon, 29 Jul 2019 21:50:00 UTC Physicians' Perspective: Desired Changes Among Retina Specialists http://www.mdmag.com/conference-coverage/asrs-2019/physicians-perspective-desired-changes-among-retina-specialists Mon, 29 Jul 2019 18:20:00 UTC Anti-VEGFs as a Treatment for Diabetic Retinopathy and PANORAMA Results http://www.mdmag.com/conference-coverage/asrs-2019/antivegfs-as-a-treatment-for-diabetic-retinopathy-and-panorama-results Mon, 29 Jul 2019 16:28:00 UTC Aflibercept Injections Found to Have No Prophylactic Impact http://www.mdmag.com/conference-coverage/asrs-2019/aflibercept-injections-found-to-have-no-prophylactic-impact Mon, 29 Jul 2019 15:19:00 UTC Learning About nAMD Treatment from Individual Responses http://www.mdmag.com/conference-coverage/asrs-2019/learning-about-namd-treatment-from-individual-responses Mon, 29 Jul 2019 00:30:00 UTC Ajay Kuriyan, MD: Educating Patients on Stem Cells http://www.mdmag.com/conference-coverage/asrs-2019/ajay-kuriyan-md-educating-patients-on-stem-cells Sun, 28 Jul 2019 21:50:00 UTC LADDER Demonstrates Efficacy of Port Delivery System with Ranibizumab http://www.mdmag.com/conference-coverage/asrs-2019/ladder-demonstrates-efficacy-of-port-delivery-system-with-ranibizumab Sun, 28 Jul 2019 21:16:00 UTC ALK4290 and Potential of Oral Therapies for Neovascular AMD http://www.mdmag.com/conference-coverage/asrs-2019/alk4290-and-potential-of-oral-therapies-for-neovascular-amd Sun, 28 Jul 2019 12:00:00 UTC Advantages of Brolucizumab in a Clinical Setting http://www.mdmag.com/conference-coverage/asrs-2019/advantages-of-brolucizumab-in-a-clinical-setting Sun, 28 Jul 2019 10:00:00 UTC Results of FIDO Study and Impact of 10-Year Anti-VEGF Dosing http://www.mdmag.com/conference-coverage/asrs-2019/results-of-fido-study-and-impact-of-10year-antivegf-dosing Sat, 27 Jul 2019 21:08:00 UTC Carl Regillo, MD: Brolucizumab as a Treatment for Macular Degeneration http://www.mdmag.com/conference-coverage/asrs-2019/carl-regillo-md-brolucizumab-as-a-treatment-for-macular-degeneration Sat, 27 Jul 2019 18:02:00 UTC Risuteganib for Patients with Dry Age-Related Macular Degeneration http://www.mdmag.com/conference-coverage/asrs-2019/risuteganib-for-patients-with-dry-agerelated-macular-degeneration Sat, 27 Jul 2019 16:10:00 UTC W. Lloyd Clark, MD: Ways to Improve Noncompliance http://www.mdmag.com/conference-coverage/asrs-2019/w-lloyd-clark-md-ways-to-improve-noncompliance Sat, 27 Jul 2019 12:00:00 UTC W. Lloyd Clark, MD: Burnout Among Retina Specialists, Ophthalmologists http://www.mdmag.com/conference-coverage/asrs-2019/w-lloyd-clark-md-burnout-among-retina-specialists-ophthalmologists Sat, 27 Jul 2019 10:00:00 UTC W. Lloyd Clark, MD: Choosing Between Anti-VEGF Treatments http://www.mdmag.com/conference-coverage/asrs-2019/w-lloyd-clark-md-choosing-between-antivegf-treatments Fri, 26 Jul 2019 21:08:00 UTC